Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Comment by donmayneon Mar 18, 2018 1:43pm
375 Views
Post# 27735972

RE:RE:RE:VMD should be $6 today

RE:RE:RE:VMD should be $6 todaySince the VMD spinoff, the $US/$Cdn exchange rate has increased by 4-5%.  This suggests that the price rise since the spinoff is insignificant.

After a 2017Q3 net profit of $US 3.3 million, the 2017Q4 net showed a slight loss. This is a decline of more than $US3.3 million. One time spinoff expenses and allocating the senior management incentive options in the fourth quarter (as opposed to spreading them out over the year) were factors. 

The Revenue growth from 2017Q4 to 2018Q1 is looking to be 5% rather than the expected 40% y/y projected rate.

Notwithstanding the restriction on Crawford selling more than 15% of his shares in any single month, he appears to have transferred 100% of them. No explanation. Others like him would like to move on from their historical investment but don't have the arranged trade opportunity lined up like he apparently did for his significant holdings. As the market price reaches their selling target they will unwind their holdings.  This leaves a significant overhang. 

A prospective fund investor knows that the thin trading means any investment is literally locked in. Thereafter any attempts to sell will significantly depress the price.

If the price were to dip below $3, there would probably be some margin calls from the recent buying.  Perhaps not much but some.

Hoyt is focused on a roadshow in Canada marketing VMD's story to investors. Some believe he should be in the US building the company to develop a track record that will attract investors. Hoyt's track record is as the owner of a private company that did well when reimbursement rates were 35% higher.  

In summary, VMD is a great story amongst many investment opportunities with an attractive story.  The investments that succeed will be those who demonstrate they are more than a story.   

This is what investing is all about. Either invest in the story knowing that some stories are not going to work out or wait for a track record and buy at higher prices.  








Bullboard Posts